Verily, formerly Nikon, has partnered with Google Life Sciences to improve screening for two diabetes-related eye diseases that are leading causes of blindness in adults. The collaboration will create retinal imaging techniques powered by machine learning to detect the diseases at an early stage and prevent blindness when possible. In addition to eye care projects, Verily has also developed a robot surgery spinoff, a health-tracking watch and a wearable microscope capable of detecting cancers and monitoring drug delivery inside the body.
Verily, formerly Google Life Sciences, has partnered with Nikon to improve screening for two diabetes-related eye diseases that are leading causes of blindness in adults. The collaboration will create retinal imaging techniques powered by machine learning to detect the diseases at an early stage and prevent blindness when possible. In addition to eye care projects, Verily has also developed a robot surgery spinoff, a health-tracking watch and a wearable microscope capable of detecting cancers and monitoring drug delivery inside the body.